Few treatments in modern medicine have arrived with more noise than GLP-1s. Underneath the conversation is straightforward physiology: these medications regulate blood sugar, appetite and metabolism to support weight management and broader metabolic health. Here is how the two we’re asked about most — semaglutide and tirzepatide — compare.
Semaglutide: the classic GLP-1.
Semaglutide mimics your natural GLP-1 hormone, signaling the brain to promote fullness and reduce cravings. It also slows gastric emptying, which steadies blood sugar and quiets appetite between meals.
- Administration: once-weekly injection, or an oral tablet form
- Key effects: reduced appetite, improved portion control, steady weight loss
- Additional benefits: lowers blood sugar, and may reduce cardiovascular risk in overweight individuals or those with type 2 diabetes
Tirzepatide: the dual-action newcomer.
Tirzepatide works on two natural hormone pathways, GLP-1 and GIP, regulating appetite and metabolism together. That combination often produces greater improvements in glucose control and significant weight loss.
- Administration: once-weekly injection
- Key effects: strong appetite suppression, enhanced fat and glucose metabolism
- Comparative advantage: often faster results, with potentially fewer side effects such as nausea
Side by side.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Hormones targeted | GLP-1 only | GLP-1 + GIP (dual action) |
| Dosing | Once-weekly injection | Once-weekly injection |
| Key effects | Appetite control, blood sugar regulation | Strong appetite control, higher fat & glucose metabolism |
| Results | Steady weight loss | Often greater weight loss |
How they work, day to day.
Appetite and intake. Central GLP-1 signaling decreases hunger and cravings, while slower gastric emptying increases satiety — the practical result is lower calorie intake and gradual, clinically significant weight loss.
Blood sugar regulation. These medications trigger appropriate insulin release when glucose is elevated, reduce glucagon and decrease hepatic glucose output — lowering A1c with minimal hypoglycemia risk when used appropriately.
Cardiometabolic risk. Improvements are seen in weight, blood pressure and lipid profiles, and semaglutide carries cardiovascular outcomes data showing MACE reduction.
What results tend to look like.
In studies pairing once-weekly semaglutide with nutrition and exercise support, participants lost a significant amount of weight over a year or more, with most people noticing gradual, consistent loss alongside improvements in blood sugar, cholesterol and heart health. Clinical studies of tirzepatide over roughly a year showed major reductions in body weight plus gains in energy, glucose control and waist circumference — and many users report a stronger appetite-suppressing effect and faster initial progress compared with semaglutide.
The honest conversation about side effects.
Common, and usually transient: nausea, vomiting, diarrhea or constipation, and abdominal discomfort — often mitigated by slow dose titration, smaller meals and pausing dose increases during illness.
Serious but less common: pancreatitis (a GLP-1 class warning — discontinue and seek care for severe, persistent abdominal pain), gallbladder events, dehydration from GI losses, and worsening of diabetic retinopathy with rapid A1c improvement, which we monitor where applicable.
Not ideal for: anyone with active pancreatitis, who is pregnant or planning to conceive imminently, or with contraindicated medical conditions. This is exactly why our program is medically supervised.
Benefits beyond the scale.
GLP-1s were born in diabetes care, and their reach extends well past weight: support for heart health through improved blood sugar control and reduced inflammation, steadier glucose, protection of kidney function, healthier liver-fat markers, naturally improved portion control, and emerging signals around mood, reward pathways and emotional eating. Many clients also report better sleep as inflammation settles and glucose stabilizes. It’s a whole-body story — from the inside out.
How it works at Rejuvia.
GLP-1 therapy here is a supervised medical program, not a prescription in passing. You begin with a consultation and appropriate lab work, so your provider can confirm candidacy and choose between semaglutide and tirzepatide based on your health history and goals. Dosing is titrated slowly to keep side effects manageable, and regular check-ins let us adjust as your body responds. Medication is one tool; the oversight around it is what makes the results safe and sustainable.